Abstract
Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that can lead to decreased health-related quality of life and permanent joint damage leading to functional decline. In addition to joint and skin manifestations, both psoriasis and PsA are associated with numerous comorbidities and extraarticular/cutaneous manifestations, which may influence the physician's choice of therapy. The objectives of this review are (1) to identify comorbidities in patients with PsA based on the available evidence; (2) to examine the effects of these comorbidities or extraarticular/cutaneous manifestation on the management of patients with PsA as well as the selection of therapy; and (3) to highlight research needs around comorbidities and treatment paradigms. This review is part of a treatment recommendations update initiated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2315-2322 |
| Number of pages | 8 |
| Journal | Journal of Rheumatology |
| Volume | 41 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 1 2014 |
Fingerprint
Keywords
- Autoimmune ophthalmic disease
- Cardiovascular
- Diabetes
- Disease obesity
- Metabolic syndrome
- Osteoporosis
ASJC Scopus subject areas
- Rheumatology
- Immunology
- Immunology and Allergy
Cite this
Comprehensive treatment of psoriatic arthritis : Managing comorbidities and extraarticular manifestations. / Ogdie, Alexis; Schwartzman, Sergio; Eder, Lihi; Maharaj, Ajesh B.; Zisman, Devy; Raychaudhuri, Siba P; Reddy, Soumya M.; Husni, Elaine.
In: Journal of Rheumatology, Vol. 41, No. 11, 01.11.2014, p. 2315-2322.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Comprehensive treatment of psoriatic arthritis
T2 - Managing comorbidities and extraarticular manifestations
AU - Ogdie, Alexis
AU - Schwartzman, Sergio
AU - Eder, Lihi
AU - Maharaj, Ajesh B.
AU - Zisman, Devy
AU - Raychaudhuri, Siba P
AU - Reddy, Soumya M.
AU - Husni, Elaine
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that can lead to decreased health-related quality of life and permanent joint damage leading to functional decline. In addition to joint and skin manifestations, both psoriasis and PsA are associated with numerous comorbidities and extraarticular/cutaneous manifestations, which may influence the physician's choice of therapy. The objectives of this review are (1) to identify comorbidities in patients with PsA based on the available evidence; (2) to examine the effects of these comorbidities or extraarticular/cutaneous manifestation on the management of patients with PsA as well as the selection of therapy; and (3) to highlight research needs around comorbidities and treatment paradigms. This review is part of a treatment recommendations update initiated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
AB - Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that can lead to decreased health-related quality of life and permanent joint damage leading to functional decline. In addition to joint and skin manifestations, both psoriasis and PsA are associated with numerous comorbidities and extraarticular/cutaneous manifestations, which may influence the physician's choice of therapy. The objectives of this review are (1) to identify comorbidities in patients with PsA based on the available evidence; (2) to examine the effects of these comorbidities or extraarticular/cutaneous manifestation on the management of patients with PsA as well as the selection of therapy; and (3) to highlight research needs around comorbidities and treatment paradigms. This review is part of a treatment recommendations update initiated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
KW - Autoimmune ophthalmic disease
KW - Cardiovascular
KW - Diabetes
KW - Disease obesity
KW - Metabolic syndrome
KW - Osteoporosis
UR - http://www.scopus.com/inward/record.url?scp=84922413739&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922413739&partnerID=8YFLogxK
U2 - 10.3899/jrheum.140882
DO - 10.3899/jrheum.140882
M3 - Article
C2 - 25362717
AN - SCOPUS:84922413739
VL - 41
SP - 2315
EP - 2322
JO - Journal of Rheumatology
JF - Journal of Rheumatology
SN - 0315-162X
IS - 11
ER -